WuXi Healthcare Ventures

WuXi Healthcare Ventures

WuXi Healthcare Ventures

Suggest edits
Follow us
Also headquartered in Cambridge
Terms of Service Privacy Policy Cookie Statement
Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 18

Portfolio

Portfolio Tracker

Add info
Add round
02 Jan 2019
Antengene Corporation
Antengene Corporation
$120,000,000
Venture capital (Series B)
Celgene, QiMing Venture Partners, Boyu Capital, +3

China’s Antengene raises $120m Series B round

AVCJ
+2
02 May 2018
Refuge Biotechnologies
Refuge Biotechnologies
$25,000,000
Venture capital (Series B)
Danhua Capital, WuXi Healthcare Ventures, Sequoia China, +5

Refuge Biotechnologies racks up $25 mln Series B

PE HUB
15 Mar 2018
IDEAYA Biosciences
IDEAYA Biosciences
$94,000,000
Venture capital (Series B)
Canaan Partners, Roche Venture Fund, 5AM Ventures, +10

Ideaya Biosciences Raises $94M Crossover Series B Financing

FinSMEs
27 Nov 2017
Medeor Therapeutics
Medeor Therapeutics
$57,000,000
Venture capital (Series B)
RA Capital Management, Sofinnova Ventures, WuXi Healthcare Ventures, +2
20 Sep 2017
XW Laboratories
XW Laboratories
$17,500,000
Venture capital (Series B)
WI Harper Group, Johnson & Johnson Innovation, WuXi Healthcare Ventures, +3
18 Sep 2017
LifeMine Therapeutics
LifeMine Therapeutics
$55,000,000
Venture capital (Series A)
Foresite Capital, ARCH Venture Partners, Boyu Capital, +5
28 Jun 2017
Vivace Therapeutics, Inc.
Vivace Therapeutics, Inc.
$25,000,000
Venture capital (Series B)
Canaan Partners, Sequoia Capital, WuXi Healthcare Ventures, +2

Cancer-Focused Vivace Emerges with $40M in Financing Genetic Engineering & Biotechnology News - Biotech from Bench to Business

GEN
+1
18 Aug 2016
Avelas Biosciences
Avelas Biosciences
$20,000,000
Venture capital (Series C)
Avalon Ventures, Ervington Investments, WuXi Healthcare Ventures, +3

Avelas Bio Raises $20M to Push Cancer-Illuminating Biologic Agent

Xconomy
+1
18 Aug 2016
Nutrinia
Nutrinia
$30,000,000
Venture capital (Series D)
TPG Biotech, OrbiMed, WuXi Healthcare Ventures, +2

Nutrinia Announces $30 Million Series D Financing to Fund Clinical Development of Lead Product | Business Wire

businesswire
+3
03 Jul 2016
CStone Pharmaceuticals
CStone Pharmaceuticals
$150,000,000
Venture capital (Series A)
Boyu Capital, WuXi Healthcare Ventures, Oriza Seed Capital
04 May 2016
IDEAYA Biosciences
IDEAYA Biosciences
$46,000,000
Venture capital (Series A)
Canaan Partners, Celgene, 5AM Ventures, +3
19 Jan 2016
Twist Bioscience
Twist Bioscience
$61,000,000
Venture capital (Series D)
Foresite Capital, ARCH Venture Partners, Paladin Capital Group, +13

Same Twist, New Funding: Gene Synthesizer Raises $61M Series D

Xconomy
+1
12 Jan 2016
Syros Pharmaceuticals
Syros Pharmaceuticals
$40,000,000
Venture capital (Series C)
Redmile Group, Polaris Partners, Aisling Capital, +5

Syros Pharma raises $40 mln

PE Hub
+1
15 Dec 2015
AltheaDx
AltheaDx
$30,000,000
Venture capital (Series C)
WuXi Healthcare Ventures, WuXi PharmaTech, Ally Bridge Group, +1

AltheaDx Raises $30M to Help Doctors Personalize Treatment

Xconomy
+1
03 Nov 2015
Lumo Bodytech
Lumo Bodytech
$10,000,000
Venture capital (Series B)
AME Cloud Ventures, Innovation Endeavors, Madrona Venture Group, +3

Lumo Raises $10 Million Series B, Starts Building Wearables Partnerships

TechCrunch
01 Sep 2015
Ivenix
Ivenix
$42,000,000
Private equity
Cardinal Partners, Fidelity Biosciences, SCP Vitalife Partners, +2

Ivenix Inc. Secures $42 Million in Funding

Ivenix, Inc.
03 Jul 2015
23andMe
23andMe
$115,000,000
Venture capital (Series E)
Experiment Fund, Fidelity Management & Research, Casdin Capital, +1

23andMe brings in $115M in Series E funding

MedCity News
+1